Autologous CAR T cell production, administration and monitoring Dinesh Khanna @RheumNow #EULAR2025 https://t.co/zrXjxSCRgl

• https://x.com/synovialjoints/status/1933787992759599579/photo/1

EULAR/ACR Classification Criteria for #ASyS, the new acronym of Antisynthetase Syndrome 🔺️Do not apply if patient is positive for other antibodies like SSA #EULAR2025 @RheumNow https://t.co/AD5tTipBtt

• https://x.com/Nellziade/status/1933789191764119789/photo/1

FMF #Recommendations #Colchicine can be fatal 🔺️Monitor regularly #EULAR2025 @RheumNow https://t.co/VJZYPaBrvE

• https://x.com/Nellziade/status/1933789626692509988/photo/1

Why do people not respond to psoriatic arthritis therapies? #EULAR2025 @RheumNow https://t.co/VGLN0R3TyY

• https://x.com/drdavidliew/status/1933791747634835900/photo/1

What is the difference between difficult to treat, and treatment-refractory? (see these criteria for PsA) Treatment refractory means that co-morbidities, psychosocial issues and other factors have been managed adequately, but inflammation keeps on going #EULAR2025 @RheumNow https://t.co/Fzpf0eiCWY

• https://x.com/drdavidliew/status/1933793898075140152/photo/1

FMF #Recommendations #Colchicine can be fatal 🔺️Beware of drug interactions 🔺️Mostly statins in adults 🔺️Macrolides in children #EULAR2025 @RheumNow https://t.co/SYGLpAJXFu

• https://x.com/Nellziade/status/1933794041214148656/photo/1

Joint pain and fatigue are actually the biggest issues for people living with haemochromatosis, but we in rheumatology don’t have organized care for them. A call to action from Patrick Kiely, to do better by these patients #EULAR2025 @RheumNow https://t.co/h3Zvov642L

• https://x.com/drdavidliew/status/1933795430396989936/photo/1

Manifestations of relapsing polychondritis @Lupusreference @RheumNow #EULAR2025 https://t.co/EuPOdKKjax

• https://x.com/synovialjoints/status/1933795550425444667/photo/1

The ‘iron fist’ of haemochromatosis arthropathy, and other key features: Patrick Kiely #EULAR2025 @RheumNow https://t.co/grs1Tq3GAk

• https://x.com/drdavidliew/status/1933796191638048898/photo/1
• https://x.com/drdavidliew/status/1933796191638048898/photo/1
• https://x.com/drdavidliew/status/1933796191638048898/photo/1

Which CAR-based strategies would you consider to treat severe refractory #SLE based on data presented at #EULAR2025? @RheumNow

POETYK PsA-1 Deucravacitinib TYK2i RCT Ph 3 ACR 20 DEU 54% vs. 34% PBO wk 16 ACR 50 DEU 23% vs. 14% PBO also significant diff for HAQ-DI PASI 75 SF-36 PCS and MDA Less Rx progression @RheumNow #EULAR2025 LB0001 https://t.co/oRLlHwI4Bh

• https://x.com/AurelieRheumo/status/1933797602711179482/photo/1

Why do we need RA treatment recommendation updates? We keep on getting new data, for our keystone disease so today Josef Smolen and colleagues present the new 2025 EULAR recommendations #EULAR2025 @RheumNow https://t.co/OdHL8CAIKv

• https://x.com/drdavidliew/status/1933798694023016841/photo/1

#ClinicalPearls For #cartilage #swelling in #relapsing #polychrondritis Ask for #pics #Levamisole in #cocaine #infection - uncommon - from piercing Acute #bacterial v chronic #lymphoma #malignancy #vasculitis #Trauma Hx, duration, fever can be helpful #EULAR2025 @RheumNow https://t.co/X2b6VHYsYa

• https://x.com/Janetbirdope/status/1933798786968571952/photo/1
• https://x.com/Janetbirdope/status/1933798786968571952/photo/1

RCT of a digital intervention in RMDs? It was long awaited, and all the lights are green🟢! German national Bechterew-App RCT of App based intervention AXIA, control group was standard of care 200pts 12wks ASAS20 response 51% vs. 9% ASAS40 response rate 23% vs. 3% BASDAI:

1st #recommendations for #Hemochromatosis #arthropathy #psuedogout #CPPD #calcium #pyrophosphate #arthritis #EULAR2025 #Recommenadations II @RheumNow @eular_org https://t.co/AnE4T2wYoa

• https://x.com/Janetbirdope/status/1933799696960794940/photo/1